FRIDAY, April 25, 2025 (HealthDay News) — Novavax’s COVID-19 vaccine could soon receive full approval from the U.S. Food and Drug Administration (FDA), the company said Wednesday. The update sent Novavax’s stock up more than 21% in early trading. It also helped ease fears that the decision had been delayedContinue Reading
Approval granted for adults and children 12 years and older who remain symptomatic despite antihistamine treatmentContinue Reading
WEDNESDAY, April 23, 2025 (HealthDay News) — Teen cannabis use rose significantly in parts of Canada after edibles were legalized, a new study shows. The study found a 26% increase in teen cannabis use in provinces that began selling cannabis edibles and extracts in October 2019. Use of edibles aloneContinue Reading
WEDNESDAY, April 23, 2025 (HealthDay News) — Overuse of antibiotics might increase kids’ risk of developing asthma and allergies, by disrupting their gut bacteria during a crucial stage of child development, a new study says. Exposure to antibiotics prior to age 2 is associated with a 24% increased risk ofContinue Reading
WEDNESDAY, April 23, 2025 (HealthDay News) — Recreational use of “magic mushroom” psilocybin skyrocketed in the U.S. during the early 2020s, as states began toying with legalization of the psychedelic drug, a new study says. The number of adults 30 and older who had used psilocybin in the past yearContinue Reading
Pharmaceutical company and federal agency warn consumers not to use the counterfeit medicationContinue Reading
MONDAY, April 21, 2025 (HealthDay News) — Colonoscopy for younger adults. Chest CT scans for lung cancer. Statin meds to lower cholesterol. Screening for drug addiction. More than 150 million Americans might lose no-cost access to these and other preventive care services under a case being heard Monday at theContinue Reading
FRIDAY, April 18, 2025 (HealthDay News) — A new pill designed to help with weight loss and blood sugar control is showing promise in early studies. Eli Lilly said its experimental drug, orforglipron, helped people with type 2 diabetes lower their blood sugar and lose weight. The company is hopingContinue Reading
THURSDAY, April 17, 2025 (HealthDay News) — A panel of federal health experts on Wednesday recommended expanded vaccine options for several diseases, including respiratory syncytial virus (RSV), meningitis and a mosquito-borne illness called chikungunya. The panel, known as the Advisory Committee on Immunization Practices (ACIP), makes vaccine use recommendations toContinue Reading
THURSDAY, April 17, 2025 (HealthDay News) — Hepatitis A vaccinations could be lagging among men who have sex with men due to a mistrust of medicine, particularly among racial and ethnic minority groups, a new study says. Only about 60% of surveyed gay and bisexual men were fully vaccinated forContinue Reading
Approval granted for patients with generalized myasthenia gravis or chronic inflammatory demyelinating polyneuropathyContinue Reading
The CheckMate-9DW trial showed significant overall survival benefit versus lenvatinib or sorafenibContinue Reading
TUESDAY, April 15, 2025 (HealthDay News) — People hospitalized for opioid use can better fight their addiction if their path to recovery begins in the hospital, a new study says. Opioid users who receive addiction consultation services during their hospital stay are significantly more likely to start taking addiction medsContinue Reading
New strategy aims to enhance drug safety, expedite evaluation process, and decrease animal experimentationContinue Reading